Update on cytomegalovirus infections of the gastrointestinal system in solid organ transplant recipients

Current Infectious Disease Reports

Volumn 14, Issue 1, 2012, Pages 33-40

  Lemonovich, Tracy L ^a   Watkins, Richard R ^b,c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b AKRON GENERAL MEDICAL CENTER   (United States)

^c Northeast Ohio Medical University   (United States)

Author keywords

CMV; Cytomegalovirus; Gastrointestinal infection; Solid organ transplant

Indexed keywords

ARTESUNATE; BENZIMIDAVIR; CIDOFOVIR; CIDOFOVIR 3 HEXADECYLOXYPROPYL ESTER; CYTOMEGALOVIRUS ANTIBODY; CYTOMEGALOVIRUS VACCINE; DNA POLYMERASE; FOSCARNET; GANCICLOVIR; GLYCOPROTEIN B VACCINE; IMMUNOGLOBULIN; LEFLUNOMIDE; PEPTIDE VACCINE; RAPAMYCIN; UNCLASSIFIED DRUG; VALGANCICLOVIR;

ADOPTIVE TRANSFER; ANTIVIRAL RESISTANCE; CELLULAR IMMUNITY; CLINICAL FEATURE; COLITIS; CYTOMEGALOVIRUS INFECTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG MONITORING; ESOPHAGITIS; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL INFECTION; GRAFT DYSFUNCTION; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; KIDNEY FUNCTION; MORBIDITY; MORTALITY; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT INFECTION; REVIEW; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; TREATMENT DURATION; VIRUS CULTURE; VIRUS LOAD; VIRUS MUTATION; VIRUS REACTIVATION;

EID: 84857628883     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-011-0224-6     Document Type: Review

References (70)

1. AJ Eid RR Razonable 2010 New developments in the management of cytomegalovirus infection after solid organ transplantation Drugs 70 965 981 20481654 10.2165/10898540-000000000-00000 1:CAS:528:DC%2BC3cXptlalsb0%3D Excellent review of recent management issues in CMV infection after SOT
2. A Loewendorf CA Benedict 2010 Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything J Intern Med 267 483 501 20433576 10.1111/j.1365-2796.2010.02220.x 1:CAS:528:DC%2BC3cXmsleqtrc%3D
3. CN Kotton 2010 Management of cytomegalovirus infection in solid organ transplantation Nat Rev Nephrol 6 711 721 20978468 10.1038/nrneph.2010.141
4. FN Ozdemir A Akgul A Altunoglu, et al. 2007 The association between cytomegalovirus infection and atherosclerotic events in renal transplant recipients Transplant Proc 39 990 992 17524871 10.1016/j.transproceed.2007.02. 026 1:STN:280:DC%2BD2szhtlSjtw%3D%3D (Pubitemid 46764827)
5. E Rodrigo G Fernandez-Fresnedo R Valero, et al. 2006 New-onset diabetes after kidney transplantation: risk factors J Am Soc Nephrol 17 Suppl 3 S291 S295 17130277 10.1681/ASN.2006080929 (Pubitemid 44865264)
6. A Hartmann S Sagedal J Hjelmesaeth 2006 The natural course of cytomegalovirus infection and disease in renal transplant recipients Transplantation 82 2 Suppl S15 S17 16858268 10.1097/01.tp.0000230460.42558.b0 (Pubitemid 44126861)
7. DA Bobak 2003 Gastrointestinal infections caused by cytomegalovirus Curr Infect Dis Rep 5 101 107 12641994 10.1007/s11908-003-0044-4 (Pubitemid 38899165)
8. R Trappe H Pohl A Forberger, et al. 2007 Acute esophageal necrosis (black esophagus) in the renal transplant recipient: manifestation of primary cytomegalovirus infection Transpl Infect Dis 9 42 45 17313471 10.1111/j.1399-3062.2006.00158.x 1:STN:280:DC%2BD2s7hvVarug%3D%3D
9. N Harada M Shimada T Suehiro, et al. 2005 Unusual endoscopic findings of CMV esophagitis after liver transplantation Hepatogastroenterology 52 1236 1239 16001670 (Pubitemid 40942223)
10. W Li H Fan L Yiping 2009 Postural epigastric pain as a sign of cytomegalovirus gastritis in renal transplant recipients: a case-based review Transplant Proc 41 3956 3958 19917423 10.1016/j.transproceed.2009.05.034 1:STN:280:DC%2BD1Mjmtlyrtg%3D%3D
11. L Llado J Castellote J Fabregat, et al. 2008 Antral mass due to cytomegalovirus infection requiring gastrectomy in a liver transplant recipient Transpl Infect Dis 10 354 357 18397184 10.1111/j.1399-3062.2008.00311.x 1:STN:280:DC%2BD1cnltV2hsA%3D%3D
12. GA Talmon 2010 Histologic features of cytomegalovirus enteritis in small bowel allografts Transplant Proc 42 2671 2675 20832567 10.1016/j.transproceed. 2010.04.059 1:STN:280:DC%2BC3cfhsl2qug%3D%3D
13. E Petrilsi A Chiereghin L Gabrielli, et al. 2010 Early and late virologic monitoring of cytomegalovirus, Epstein-Barr virus, and human herpes virus 6 infections in small bowel/multivisceral transplant recipients Transplant Proc 42 74 78 10.1016/j.transproceed.2009.12.032
14. U Navaneethan PG Venkatesh J Wang 2011 Cytomegalovirus ileitis in a patient after liver transplantation- differentiating from de novo IBD J Crohns Colitis 5 354 359 21683307 10.1016/j.crohns.2011.01.010
15. M Dahman R Krell K Brayman, et al. 2010 Simultaneous Clostridium difficile-associated colitis and late-onset intestinal cytomegalovirus disease in a renal transplant recipient Ann Transplant 15 72 76 21183880
16. M Veroux L Puzzo D Corona, et al. 2007 Cytomegalovirus and Clostridium difficile ischemic colitis in a renal transplant recipient: a lethal complication of anti-rejection therapy? Urol Int 79 177 179 17851290 10.1159/000106334
17. DD Hampton MH Poleski JE Onken 2008 Inflammatory bowel disease following solid organ transplantation Clin Immunol 128 287 293 18708022 10.1016/j.clim.2008.06.011 1:CAS:528:DC%2BD1cXhtVShtrzP
18. RC Verdonk EB Haagsma AP Van Den Berg, et al. 2006 Inflammatory bowel disease after liver transplantation: a role for cytomegalovirus infection Scand J Gastroenterol 41 205 211 16484126 10.1080/00365520500206293 (Pubitemid 43247204)
19. SO Lee RR Razonable 2010 Current concepts on cytomegalovirus infection after liver transplantation World J Hepatol 2 325 336 21161017 10.4254/wjh.v2.i9.325
20. AJ Demetris 2009 Evolution of hepatitis C in liver allografts Liver Transpl 15 Suppl 2 S35 S41 19876940 10.1002/lt.21890
21. S Ramirez S Perez-Del-Pulgar X Forns 2008 Virology and pathogenesis of hepatitis C recurrence Liver Transpl 14 Suppl 2 S27 S35 18825723 10.1002/lt.21644
22. RR Razonable KW Burak H van Cruijsen, et al. 2002 The pathogenesis of hepatitis C virus is influenced by cytomegalovirus Clin Infect Dis 35 974 981 12355385 10.1086/342911 (Pubitemid 35178315)
23. M Drage A Reid CJ Callaghan, et al. 2009 Acute cytomegalovirus cholecystitis following renal transplantation Am J Transplant 9 1249 1252 19422351 10.1111/j.1600-6143.2009.02607.x 1:STN:280:DC%2BD1MzivVKlsA%3D%3D
24. AL Baroco EC Oldfield 2008 Gastrointestinal cytomegalovirus disease in the immunocompromised patient Curr Gastroenterol Rep 10 409 416 18627655 10.1007/s11894-008-0077-9
25. BS Kamalkumar SK Agarwal P Garg, et al. 2009 Acute pancreatitis with CMV papillitis and cholangiopathy in a renal transplant recipient Clin Exp Nephrol 13 389 391 19142576 10.1007/s10157-008-0123-9
26. DK Klassen CB Drachenberg JC Papadimitriou, et al. 2000 CMV allograft pancreatitis: diagnosis, treatment, and histological features Transplantation 69 1968 1971 10830244 10.1097/00007890-200005150-00042 1:STN:280: DC%2BD3c3ovFSmtA%3D%3D (Pubitemid 30340367)
27. CN Kotton D Kumar AM Caliendo, et al. 2010 International consensus guidelines on the management of cytomegalovirus in solid organ transplantation Transplantation 89 779 795 20224515 10.1097/TP.0b013e3181cee42f Recent international consensus guidelines with extensive review of the literature by international transplant experts on management of CMV in SOT
28. L Halme M Lempinen J Arola, et al. 2008 High frequency of gastroduodenal cytomegalovirus infection in liver transplant patients APMIS 116 99 106 18321360 10.1111/j.1600-0463.2008.00823.x (Pubitemid 351347592)
29. SA Grim E Pereira G Guzman, et al. 2010 CMV PCR as a diagnostic tool for CMV gastrointestinal disease after solid organ transplantation Transplantation 90 799 801 20881579 10.1097/TP.0b013e3181eceac9 Overview of recent available data on use of molecular assays for diagnosis of gastrointestinal tract disease in SOT
30. AJ Eid SK Arthurs PJ Deziel, et al. 2008 Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes Clin Transplant 22 162 170 18339135 10.1111/j.1399-0012.2007.00761.x (Pubitemid 351420009)
31. L Halme K Hockerstedt K Samela, et al. 1998 CMV infection detected in the upper gastrointestinal tract after liver transplantation Transpl Int 11 Suppl 1 S242 S244 9664987
32. EY Jang SY Park EJ Lee, et al. 2009 Diagnostic performance of the cytomegalovirus (CMV) antigenemia assay in patients with CMV gastrointestinal disease Clin Infect Dis 48 e121 e124 19441977 10.1086/599116
33. A Fica C Cervera N Perez, et al. 2007 Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests Transpl Infect Dis 9 203 210 17511827 10.1111/j.1399-3062.2007.00220.x 1:STN:280: DC%2BD2svnt1emuw%3D%3D (Pubitemid 47231211)
34. T Ganzenmueller C Henke-Gendo J Schlue, et al. 2009 Quantification of cytomegalovirus DNA levels in intestinal biopsies as a diagnostic tool for CMV intestinal disease J Clin Virol 46 254 258 19748823 10.1016/j.jcv.2009.08.008 1:CAS:528:DC%2BD1MXht1CmtrvM
35. SW Muir J Murray MA Farquharson, et al. 1998 Detection of cytomegalovirus in upper gastrointestinal biopsies from heart transplant recipients: comparison of light microscopy, immunocytochemistry, in situ hybridisation, and nested PCR J Clin Pathol 51 807 811 10193320 10.1136/jcp.51.11.807 1:STN:280: DyaK1M3gvFCjsg%3D%3D (Pubitemid 28530842)
36. JA Brainard JK Greenson CJ Vesy, et al. 1994 Detection of cytomegalovirus in liver transplant biopsies. A comparison of light microscopy, immunohistochemistry, duplex PCR and nested PCR Transplantation 57 1753 1757 8016881 1:STN:280:DyaK2c3oslCltw%3D%3D (Pubitemid 24206416)
37. A Humar D Snydman 2009 Cytomegalovirus in solid organ transplant recipients Am J Transplant 9 Suppl 4 S78 S86 20070700 10.1111/j.1600-6143.2009. 02897.x
38. A Asberg A Humar H Rollaq, et al. 2007 Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients Am J Transplant 7 2106 2113 17640310 10.1111/j.1600-6143.2007.01910.x 1:STN:280:DC%2BD2svnvFeisw%3D%3D (Pubitemid 47247057)
39. AJ Eid SK Arthurs PJ Deziel, et al. 2010 Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients Am J Transpl 10 157 161 10.1111/j.1600-6143.2009. 02861.x 1:STN:280:DC%2BC3c%2Fit1Wkug%3D%3D Study of clinical risk factors for relapse of gastrointestinal CMV disease in SOT recipients
40. AP Limaye 2002 Ganciclovir-resistant cytomegalovirus in organ transplant recipients Clin Infect Dis 35 866 872 12228824 10.1086/342385 1:CAS:528:DC%2BD38XotlGitbc%3D
41. F Li KW Kenyon KA Kirby, et al. 2007 Incidence and clinical features of ganciclovir-resistant cytomegalovirus disease in heart transplant recipients Clin Infect Dis 45 439 447 17638191 10.1086/519941 1:CAS:528: DC%2BD2sXpsVems70%3D (Pubitemid 47204459)
42. AP Limaye L Corey DM Koelle, et al. 2000 Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants Lancet 356 645 649 10968438 10.1016/S0140-6736(00)02607-6 1:CAS:528:DC%2BD3cXmtF2gsbk%3D (Pubitemid 30627592)
43. SM Bhorade NS Lurain A Jordan, et al. 2002 Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients J Heart Lung Transplant 21 1274 1282 12490272 10.1016/S1053-2498(02)00463-1 (Pubitemid 35477741)
44. AP Limaye G Raghu DM Koelle, et al. 2002 High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy J Infect Dis 185 20 27 11756977 10.1086/338143 1:CAS:528:DC%2BD38XmvFajsA%3D%3D (Pubitemid 34043012)
45. G Boivin N Goyette C Gilbert, et al. 2004 Absence of cytomegalovirus- resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients J Infect Dis 189 1615 1618 15116297 10.1086/382753 1:CAS:528:DC%2BD2cXkslOhs7c%3D (Pubitemid 38648289)
46. HA Myhre D Haug Dorenberg KI Kristiansen, et al. 2011 Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients Transplantation 92 217 223 21685829 10.1097/TP. 0b013e31821fad25 1:CAS:528:DC%2BC3MXoslOqt7Y%3D Largest outcome study to date of ganciclovir-resistant CMV infections in SOT recipients
47. G Boivin N Goyette H Rollaq, et al. 2009 Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir Antivir Ther 14 697 704 19704173
48. S Hantz F Garnier-Geoffroy MC Mazeron, et al. 2010 Drug-resistant cytomegalovirus in transplant recipients: a French cohort study J Antimicrob Chemother 65 2628 2640 20961907 10.1093/jac/dkq368 1:CAS:528:DC%2BC3cXhsVektrnN
49. WL Drew 2010 Cytomegalovirus resistance testing: pitfalls and problems for the clinician Clin Infect Dis 50 733 736 20100090 10.1086/650463 1:CAS:528:DC%2BC3cXktVSgs7o%3D Concise review of CMV resistance testing
50. P West M Schmiedeskamp H Neeley, et al. 2008 Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL 97 mutation Transpl Infect Dis 10 129 132 17605740 10.1111/j.1399-3062.2007.00249.x 1:STN:280: DC%2BD1c7ptFyjuw%3D%3D (Pubitemid 351393081)
51. RK Avery FM Marty L Strasfeld, et al. 2010 Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients Transpl Infect Dis 12 489 496 20682012 10.1111/j.1399-3062.2010.00550.x 1:CAS:528:DC%2BC3MXhs1Sqtrg%3D
52. DR Snydman 2010 Leflunomide: a small step forward in meeting the urgent need for treatment of drug-resistant cytomegalovirus infection Transplantation 90 362 363 20555303 10.1097/TP.0b013e3181e8a6c9 1:CAS:528:DC%2BC3cXhtVCmsrrK
53. MY Shapira IB Resnick S Chou, et al. 2008 Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation Clin Infect Dis 46 1455 1457 18419454 10.1086/587106 1:CAS:528:DC%2BD1cXlvVGnsr4%3D (Pubitemid 351589951)
54. LK Dropulic JI Cohen 2010 Update on new antivirals under development for the treatment of double-stranded DNA virus infections Clin Pharmacol Ther 88 610 619 20881959 10.1038/clpt.2010.178 1:CAS:528:DC%2BC3cXhtlWmurjO
55. RK Avery 2008 Update in the management of ganciclovir-resistant cytomegalovirus infection Curr Opin Infect Dis 21 433 437 18594298 10.1097/QCO.0b013e328307c7b4
56. V Kliem L Fricke T Wollbrink, et al. 2008 Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial Am J Transplant 8 975 983 18261177 10.1111/j.1600-6143.2007.02133.x 1:STN:280:DC%2BD1c3lsFWrsA%3D%3D (Pubitemid 351537752)
57. AC Kalil J Levitsky E Lyden, et al. 2005 Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients Ann Intern Med 143 870 880 16365468 (Pubitemid 46202222)
58. T Reischig P Jindra O Hes, et al. 2008 Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation Am J Transplant 8 69 77 17973956 1:CAS:528:DC%2BD1cXhslymt7w%3D
59. A Humar Y Lebranchu F Vincenti, et al. 2010 The efficacy and safety of 200 days of valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients Am J Transplant 10 1228 1237 20353469 10.1111/j.1600-6143. 2010.03074.x 1:CAS:528:DC%2BC3cXntFyjs78%3D Important efficacy study of extended duration valganciclovir prophylaxis in D+/R- kidney transplant recipients in decreasing incidence of CMV disease
60. SK Arthurs AJ Eid RA Pedersen, et al. 2008 Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation Clin Infect Dis 46 840 846 18260785 10.1086/528718 (Pubitemid 351417184)
61. AA Boudreault H Xie RM Rakita, et al. 2011 Risk factors for late-onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney transplant recipients who receive antiviral prophylaxis Transpl Infect Dis 13 244 249 21414119 10.1111/j.1399-3062.2011.00624.x 1:STN:280: DC%2BC3Mrms1Kgtw%3D%3D
62. S Kijpittayarit-Arthurs AJ Eid WK Kremers, et al. 2007 Clinical features and outcomes of delayed-onset primary cytomegalovirus disease in cardiac transplant recipients J Heart Lung Transplant 26 1019 1024 17919622 10.1016/j.healun.2007.07.016 (Pubitemid 47500146)
63. RR Razonable A Rivero A Rodriguez, et al. 2001 Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir J Infect Dis 184 1461 1464 11709790 10.1086/324516 1:STN:280:DC%2BD3MnmtlygtA%3D%3D (Pubitemid 33108862)
64. A Humar AP Limaye EA Blumberg, et al. 2010 Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study Transplantation 90 1427 1431 21197713 10.1097/TP.0b013e3181ff1493 1:CAS:528:DC%2BC3cXhsFGrtrnM Follow-up 2 year results of efficacy study of extended duration valganciclovir prophylaxis in D+/R- kidney transplant recipients showing long-term reduction in CMV disease
65. JK Walker LM Scholz MN Scheetz, et al. 2007 Leukopenia complicates cytomegalovirus prevention after renal transplantation with alemtuzumab induction Transplantation 83 874 882 17460557 10.1097/01.tp.0000257923.69422.4d 1:CAS:528:DC%2BD2sXksFOltL4%3D (Pubitemid 46682727)
66. RR Razonable H van Cruijsen RA Brown, et al. 2003 Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir J Infect Dis 187 1801 1808 12751039 10.1086/375194 1:CAS:528:DC%2BD3sXltFGmsbg%3D (Pubitemid 36667892)
67. T Crough R Khanna 2009 Immunobiology of human cytomegalovirus: from bench to bedside Clin Microbiol Rev 22 76 98 19136435 10.1128/CMR.00034-08 1:CAS:528:DC%2BD1MXnslKrs7o%3D
68. F Sund AK Lidehall K Claesson, et al. 2010 CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study Clin Transplant 24 401 409 19222507 10.1111/j.1399-0012.2009.00976.x
69. SA Plotkin R Higgins JB Kurtz, et al. 1994 Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients Transplantation 58 1176 1178 7992358 1:STN:280:DyaK2M%2FosVCkuw%3D%3D
70. PD Griffiths A Stanton E McCarrell, et al. 2011 Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial Lancet 377 1256 1263 21481708 10.1016/S0140-6736(11)60136-0 1:CAS:528:DC%2BC3MXksFWit7Y%3D First randomized trial of a CMV vaccine given pre-SOT showing reduction in duration of CMV viremia and ganciclovir use post-transplant in D+/R- vaccinees